azithromycin 250 mg tablets
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
CF Therapeutics Development Network Coordinating Center
Overview
azithromycin 250 mg tablets is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
azithromycin 250 mg tablets clinical trials
Explore related
Medical disclaimer. This page summarizes research about azithromycin 250 mg tablets for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.